Antimicrobial polypeptides in host defense of the respiratory tract

Journal of Clinical Investigation

Volumn 109, Issue 6, 2002, Pages 693-697

  Ganz, Tomas ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CATHELICIDIN; CATIONIC SURFACTANT; CYTOKINE; DEFENSIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 9; LACTOFERRIN; LYSOZYME; MUCIN; POLYPEPTIDE; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; TRANSCRIPTION FACTOR;

ANTIMICROBIAL ACTIVITY; CHEMICAL COMPOSITION; CYTOKINE PRODUCTION; HOST RESISTANCE; IMMUNITY; INFLAMMATION; LUNG LAVAGE; MICROBIAL ACTIVITY; NOSE SECRETION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT INFECTION; REVIEW; SECRETORY GRANULE;

EID: 0036198121     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0215218     Document Type: Review

References (56)

1. On a remarkable bacteriolytic element found in tissues and secretions
2. Activity of abundant antimicrobials of the human airway
3. Innate antimicrobial activity of nasal secretions
4. Antibacterial components in bronchoalveolar lavage fluid from healthy individuals and sarcoidosis patients
5. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid
6. Transfer of a cathelicidin peptide antibiotic gene restores bacterial killing in a cystic fibrosis xenograft model
7. Trophic slime, allergic slime
8. Pathophysiology of rhinitis. Laccoferrin and lysozyme in nasal secretions
9. Soluble proteins of bronchopulmonary secretions from patients with cystic fibrosis, asthma, and bronchitis
10. Lysozyme and lactoferrin in sputum from patients with chronic obstructive lung disease
11. Quantiration of proteins in sputum from patients with chronic obstructive lung disease. II. Determination of albumin, transferrin, alpha 1-acid glycoprotein, IgG, IgM, lysozyme and C3-complement factor
12. Lower respiratory tract lactoferrin and lysozyme arise primarily in the airways and are elevated in association with chronic bronchitis
13. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution
14. Airways inflammation in chronic bronchitis: The effects of smoking and alpha 1-antitrypsin deficiency
15. Distribution of secretory leukoprotease inhibitor in the human nasal airway
16. Purification and characterization ofdefensins from cystic fibrosis sputum
17. Antibacterial peptides in bronchoalveolar lavage fluid
18. Production of β-defensins by human airway epithelia
19. CD 14-dependent lipopolysaccharide-induced beta-defensin-2 expression in human tracheobronchial epithelium
20. Bactericidal activity of human lysozyme, muramidase-inactive lysozyme, and cationic polypeptides against Streptococcus sanguis and Streptococcus faecalis: Inhibition by chitin oligosaccharides
21. Killing of gram-negative bacteria by lactoferrin and lysozyme
22. Bacterial killing is enhanced by expression of lysozyme in the lungs of transgenic mice
23. A bactericidal effect for human lactoferrin
24. Bactericidal activity of human lactoferrin: Differentiation from the stasis of iron deprivation
25. Antibacterial activity of antileukoprotease
26. Suppression of macrophage responses to bacterial lipopolysaccharide by a non-secretory form of secretory leukocyte protease inhibitor
27. Defensins: Antimicrobial and cytotoxic peptides of mammalian cells
28. Paneth cells of the human small intestine express an antimicrobial peptide gene
29. Defensin-6 mRNA in human Paneth cells: Implications for antimicrobial peptides in host defense of the human bowel
30. hBD-1: A novel beta-defensin from human plasma
31. Human beta-defensin-1: An antimicrobial peptide of urogenital tissues
32. A peptide antibiotic from human skin
33. Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic
34. Discovery of new human beta-defensins using a genomics-based approach
35. Widespread expression of beta-defensin HBD-1 in human secretory glands and epithelial cells
36. Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung
37. Inducible expression of an antibiotic peptide gene in lipopolysaccharide-challenged tracheal epithelial cells
38. Mucus clearance as a primary innate defense mechanism for mammalian airways
39. Secretion of microbicidal α-defensins by intestinal Paneth cells in response to bacteria
40. Defensins
41. Effect of defensins on interleukin-8 synthesis in airway epithelial cells
42. Regulation of SLPI and elafin release from bronchial epithelial cells by neutrophil defensins
43. Beta-defensins: Linking innate and adaptive immunity through dendritic and T cell CCR6
44. Defensins and host defense
45. Cathelicidins: A novel protein family with a common proregion and a variable C-terminal antimicrobial domain
46. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3
47. Human CAP18: A novel antimicrobial lipopolysaccharide-binding protein
48. The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes
49. The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils
50. The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders
51. The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6
52. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface
53. Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils
54. Protegrins: New antibiotics of mammalian origin
55. Augmentation of innate host defense by expression of a cathelicidin antimicrobial peptide
56. Inhibition of neutrophil elastase prevents cathelicidin activation and impairs clearance of bacteria from wounds